NEONATAL SCREENING FOR CONGENITAL HYPOTHYROIDISM IN ROMANIA: DATA FROM MEDILOG MEDICAL INFORMATION REGISTRY.

M. Nanu, I. Ardeleanu, F. Brezan, I. Nanu, A. Apostol, F. Moldovanu, H. Lăzărescu, M. Gheorghiu, A. Kozma
{"title":"NEONATAL SCREENING FOR CONGENITAL HYPOTHYROIDISM IN ROMANIA: DATA FROM MEDILOG MEDICAL INFORMATION REGISTRY.","authors":"M. Nanu, I. Ardeleanu, F. Brezan, I. Nanu, A. Apostol, F. Moldovanu, H. Lăzărescu, M. Gheorghiu, A. Kozma","doi":"10.4183/AEB.2019.209","DOIUrl":null,"url":null,"abstract":"Objective\nCongenital hypothyroidism (CH) is one of the common preventable causes of intellectual disability in neonates, by early detection through neonatal screening. We present the 8-year experience of the National Institute for Mother and Child Health (INSMC) in using MEDILOG national registry for the neonatal screening of CH.\n\n\nMethods\nNeonatal screening for CH, done by TSH measurement in dried blood spot, is organized in 5 regional centers, each with a reference laboratory.\n\n\nResults\nIn 2018 80% of all the newborns, from 80% of the maternity hospitals, were registered in MEDILOG. After re-testing of TSH and T4/FT4 from venous blood in positive cases, the incidence of confirmed CH in 2018 was 1/3576 - 1/ 4746. In INSMC center (which includes 26 counties and Bucharest, out of 41 counties), in 2018 the incidence of positive CH cases at screening was 1/2094 (TSH cut-off ≥17 mIU/L) and of confirmed CH cases 1/3576 newborns. For positive screening cases, the median duration from birth to the INSMC laboratory result was 19 days: median of 9 days between screening and laboratory registration and 6 days between registration and test result.\n\n\nConclusion\nMEDILOG registry is a practical instrument for monitoring the steps of neonatal CH screening, the incidence of CH, the evolution of the diagnosed cases, for evaluation of iodine deficiency (by neonatal TSH), and also for research, with the aim of improving early disease detection and treatment.","PeriodicalId":6910,"journal":{"name":"Acta endocrinologica","volume":"43 1","pages":"209-214"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta endocrinologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4183/AEB.2019.209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Objective Congenital hypothyroidism (CH) is one of the common preventable causes of intellectual disability in neonates, by early detection through neonatal screening. We present the 8-year experience of the National Institute for Mother and Child Health (INSMC) in using MEDILOG national registry for the neonatal screening of CH. Methods Neonatal screening for CH, done by TSH measurement in dried blood spot, is organized in 5 regional centers, each with a reference laboratory. Results In 2018 80% of all the newborns, from 80% of the maternity hospitals, were registered in MEDILOG. After re-testing of TSH and T4/FT4 from venous blood in positive cases, the incidence of confirmed CH in 2018 was 1/3576 - 1/ 4746. In INSMC center (which includes 26 counties and Bucharest, out of 41 counties), in 2018 the incidence of positive CH cases at screening was 1/2094 (TSH cut-off ≥17 mIU/L) and of confirmed CH cases 1/3576 newborns. For positive screening cases, the median duration from birth to the INSMC laboratory result was 19 days: median of 9 days between screening and laboratory registration and 6 days between registration and test result. Conclusion MEDILOG registry is a practical instrument for monitoring the steps of neonatal CH screening, the incidence of CH, the evolution of the diagnosed cases, for evaluation of iodine deficiency (by neonatal TSH), and also for research, with the aim of improving early disease detection and treatment.
罗马尼亚先天性甲状腺功能减退的新生儿筛查:来自medilog医学信息登记处的数据。
目的生殖道甲状腺功能减退症(CH)是新生儿智力障碍常见的可预防原因之一,可通过新生儿筛查早期发现。我们介绍了国家妇幼健康研究所(INSMC)在使用MEDILOG国家登记系统进行新生儿CH筛查方面的8年经验。方法通过测定干血斑TSH来进行新生儿CH筛查,在5个区域中心组织,每个中心都有参考实验室。结果2018年,80%的妇产医院80%的新生儿在MEDILOG中进行了登记。经重新检测阳性病例静脉血TSH和T4/FT4, 2018年确诊CH的发病率为1/3576 ~ 1/ 4746。在INSMC中心(包括41个县中的26个县和布加勒斯特),2018年筛查时阳性CH病例的发生率为1/2094 (TSH临界值≥17 mIU/L),确诊CH病例的发生率为1/3576。对于筛查阳性的病例,从出生到INSMC实验室结果的中位数时间为19天:从筛查到实验室登记的中位数时间为9天,从登记到检测结果的中位数时间为6天。结论medilog登记是监测新生儿CH筛查步骤、CH发病率、诊断病例演变、碘缺乏症评估(通过新生儿TSH)和研究的实用工具,旨在改善疾病的早期发现和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信